Drug or treatment

Foralumab clinical trials

• 3Clinical trials
• 1Country

Newest trials

All recruiting trials (3)

• Nasal foralumab treatment for patients with non-active secondary progressive multiple sclerosis

  This study is testing if nasal foralumab can safely help people with non-active secondary progressive multiple sclerosis who have already tried it before.

  Recruiting Phase 2 Tiziana Life Sciences LTD · Boston, Massachusetts · NCT06890923

• Foralumab nasal spray for people with multiple system atrophy (Phase 2a)

  This trial will test whether foralumab given by nasal spray can be safe and help people with multiple system atrophy.

  Recruiting Phase 2 Tiziana Life Sciences LTD · Boston, Massachusetts · NCT06868628

• Nasal foralumab to reduce brain inflammation in early Alzheimer’s

  This trial will test whether nasal foralumab, given three times a week, can reduce brain immune inflammation and improve thinking in people aged 60–85 with mild cognitive impairment from early Alzheimer’s disease.

  Recruiting Phase 2 Brigham and Women's Hospital · Boston, Massachusetts · NCT06489548

Quick answers

How many clinical trials of Foralumab are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →